Research programme: eye disorder therapeutics - Inception 4
Latest Information Update: 25 Aug 2014
At a glance
- Originator Inception 4
- Class Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Eye disorders
Most Recent Events
- 01 Nov 2013 Early research in Eye disorders in USA (Ophthalmic)
- 01 Nov 2013 Early research in Eye disorders in Germany (Ophthalmic)